Clinical trial
Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1…
NCT00421473 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00421473 |
|---|---|
| Title | Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients |
| Official title | Drug Interactions Between ATOvaquone Used in MAlaria Prophylaxis and Antiretroviral Agents in HIV-1 Infected Patients (ATOMA) |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Malaria |
| Intervention type | Drug |
| Interventions | Atovaquone / Proguanil |
| Enrollment | 79 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jan 12, 2007 |
| Last update posted | Nov 12, 2020 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: